MAR 18, 2021 11:15 PM PDT

Cannabis Not as Promising as Hoped for PTSD

WRITTEN BY: Angela Dowden

Medical marijuana is used fairly routinely as a treatment for veterans suffering with PTSD (post traumatic stress syndrome). But this prescribing practice has run ahead of the evidence supporting it. Now that evidence is coming in, it looks somewhat thinner than had been hoped.

New information on the subject comes from a long awaited trial whose results landed this week in PLOS ONE.

The study, led by Marcel Bonn-Miller of the University of Pennsylvania and Sue Sisley of the Scottsdale Research Institute, was funded by a $2.2 million grant from the Colorado Department of Public Health and Environment (CDPHE) to the Multidisciplinary Association of Psychedelic Studies (MAPS). Researchers fought for seven years to obtain approval to conduct the study, and it took three more years to carry it out.

The researchers found little evidence for effectiveness of cannabis in PTSD, though it was a safe and well-tolerated treatment.

76 military veterans with PTSD (mostly men between the ages of 24 and 77) were involved in the study in which participants were randomized to receive cannabis equivalent to 2-3 joints daily, or a placebo, for 21 days prior to a 2-week washout period followed by re-randomization to one of three cannabis treatment groups. In the second phase, some participants self-administered cannabis with 12% THC over three weeks, others received an 11% CBD product with minimal THC and a third group received a balanced THC-CBD product, containing roughly 8% THC and 8% CBD. A fourth and final group received a placebo with almost zero active cannabinoids.

The results found that in this randomized placebo-controlled trial of smoked cannabis for PTSD, no active treatment statistically outperformed placebo.

All treatment groups, including placebo, showed good tolerability and significant improvements in PTSD symptoms during three weeks of treatment. In fact, nearly half of the veterans who received a placebo believed they had been given active cannabis.

The study’s authors cited several confounding factors that may have contributed to the results, including issues surrounding the quality and potency of the National Institute on Drug Abuse-supplied cannabis and the fact that the study sample included participants with a history of cannabis use.

“The recruitment of active cannabis users might have increased the potential for biased responding,” the researchers wrote. “Despite many participants already having experience with the drug, nearly half of those receiving placebo believed that they received active cannabis. Prior expectations about cannabis’ effects might explain why even those in the placebo condition reported larger than average reductions in PTSD symptoms after only 3 weeks of treatment.”

Sources: Leafly, PLOS ONE

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
MAY 27, 2021
Technology
High Amounts of TV Watching for Middle-aged Adults Could Cause Cognitive Decline
MAY 27, 2021
High Amounts of TV Watching for Middle-aged Adults Could Cause Cognitive Decline
How often do you watch T.V. each week? Each day? It turns out, the amount of T.V. you watch as a middle-aged adult could ...
JUN 01, 2021
Cannabis Sciences
Recreational Cannabis Laws Linked to Changes in Illegal Drug Market
JUN 01, 2021
Recreational Cannabis Laws Linked to Changes in Illegal Drug Market
Researchers have found that recreational cannabis laws in the US may be linked to changes in the illegal drug market.&nb ...
JUN 03, 2021
Drug Discovery & Development
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
JUN 03, 2021
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
  Researchers at the University of Nottingham in the UK and Joint Academy have found that a clinical evidence-based ...
JUN 04, 2021
Drug Discovery & Development
Scientists Identify 90 Drugs that Could be Repurposed to Fight COVID-19
JUN 04, 2021
Scientists Identify 90 Drugs that Could be Repurposed to Fight COVID-19
Researchers from The Scripps Research Institute in California have identified 90 drugs that could be repurposed for trea ...
JUN 11, 2021
Drug Discovery & Development
Laughing Gas Shows Promise in Rapid Relief of Treatment-Resistant Depression
JUN 11, 2021
Laughing Gas Shows Promise in Rapid Relief of Treatment-Resistant Depression
Researchers led by the University of Chicago Medicine and Washington University have found that low doses of laughing ga ...
Loading Comments...